Add like
Add dislike
Add to saved papers

Improving mesoscopic fluorescence molecular tomography through data reduction.

Mesoscopic fluorescence molecular tomography (MFMT) is a novel imaging technique that aims at obtaining the 3-D distribution of molecular probes inside biological tissues at depths of a few millimeters. To achieve high resolution, around 100-150μm scale in turbid samples, dense spatial sampling strategies are required. However, a large number of optodes leads to sizable forward and inverse problems that can be challenging to compute efficiently. In this work, we propose a two-step data reduction strategy to accelerate the inverse problem and improve robustness. First, data selection is performed via signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) criteria. Then principal component analysis (PCA) is applied to further reduce the size of the sensitivity matrix. We perform numerical simulations and phantom experiments to validate the effectiveness of the proposed strategy. In both in silico and in vitro cases, we are able to significantly improve the quality of MFMT reconstructions while reducing the computation times by close to a factor of two.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app